← Back to quizzesFree quiz

Protein Misfolding and Endoplasmic Reticulum

Understanding how cells manage protein folding, quality‑control, and degradation is essential for both general medicine and cellular biology. This course synthesizes key ideas from a quiz on…

20 questions~10 min
Protein Misfolding and Endoplasmic Reticulum — Qwi
0 / 20
Score: 0%
1

Why does inhibition of the proteasome by bortezomib selectively kill multiple myeloma cells more than most normal cells?

2

In neurons, why does accumulation of misfolded huntingtin protein cause irreversible damage compared to epithelial cells?

3

Which post‑translational modification in the ER directly creates the glycocalyx on the plasma membrane?

4

A cell with aneuploidy often shows increased sensitivity to proteasome inhibitors because:

5

During cotranslational translocation, what is the immediate consequence of SRP binding to the nascent peptide?

6

Which of the following best explains why the rough ER appears basophilic in optical microscopy of pancreatic acini?

7

In the ERAD pathway, which protein acts as the primary sensor for misfolded proteins?

8

Why does the presence of a hydrophobic internal signal sequence in type 2 membrane proteins prevent cleavage of the signal peptide?

9

Which enzyme catalyzes the formation of disulfide bonds in the ER lumen?

10

A cell deficient in vitamin C would most likely exhibit which defect in the ER?

11

Which of the following organelles is directly continuous with the outer nuclear membrane?

12

During synthesis of a type 1 transmembrane protein, what event signals the transition from lumenal translation to cytosolic synthesis?

13

Why are secretory proteins destined for lysosomes synthesized on the rough ER rather than the smooth ER?

14

Which cellular factor determines whether a misfolded protein is sent to ERAD versus retained for refolding?

15

In a cell line that overexpresses the chaperonin HSP60, which step of protein maturation in the ER is most directly enhanced?

16

Which of the following best describes the structural advantage of the ER’s “multi‑storey garage” organization?

17

A researcher adds a dolichol analogue that cannot be phosphorylated. Which ER modification will be most directly impaired?

18

Why does the smooth ER lack ribosomes, and how does this relate to its primary functions?

19

In the context of cancer therapy, what is the principal reason that only tumors with high protein synthesis rates respond well to proteasome inhibitors?

20

Which of the following best explains why the ER quality‑control system directs misfolded proteins to the cytosol for degradation?

Protein Misfolding and the Endoplasmic Reticulum: Core Concepts

Understanding how cells manage protein folding, quality‑control, and degradation is essential for both general medicine and cellular biology. This course synthesizes key ideas from a quiz on protein misfolding, the endoplasmic reticulum (ER), and related therapeutic strategies. Each section expands on a quiz question, providing background, mechanisms, and clinical relevance while using SEO‑friendly language.

1. Proteasome Inhibition in Multiple Myeloma

Key Question: Why does inhibition of the proteasome by bortezomib selectively kill multiple myeloma cells more than most normal cells?

Answer: Myeloma cells produce large amounts of immunoglobulin, leading to massive protein overload when degradation is blocked.

  • High secretory load: Plasma‑cell‑derived myeloma cells synthesize and secrete massive quantities of immunoglobulin (Ig). This creates a constant influx of nascent polypeptides into the ER.
  • Proteasome dependence: To prevent accumulation of misfolded Ig chains, myeloma cells rely heavily on the ubiquitin‑proteasome system (UPS). Blocking the proteasome overwhelms the ER‑associated degradation (ERAD) pathway.
  • Unfolded Protein Response (UPR): Proteasome inhibition triggers a strong UPR, leading to apoptosis when the stress cannot be resolved.
  • Therapeutic implication: Bortezomib exploits this vulnerability, making it a cornerstone drug for relapsed/refractory multiple myeloma.

Search terms: bortezomib mechanism of action, multiple myeloma proteasome inhibition, immunoglobulin overload, ER stress therapy.

2. Neuronal Sensitivity to Misfolded Huntingtin

Key Question: In neurons, why does accumulation of misfolded huntingtin protein cause irreversible damage compared to epithelial cells?

Answer: Neurons lack a stem cell compartment and cannot replace lost cells.

  • Post‑mitotic nature: Most neurons are terminally differentiated; they do not undergo cell division to replace damaged cells.
  • Limited proteostasis capacity: Neurons have a relatively low turnover of chaperones and proteasome activity compared with rapidly dividing epithelial cells.
  • Axonal transport dependence: Misfolded huntingtin interferes with microtubule‑based transport, disrupting synaptic function.
  • Clinical relevance: This explains the progressive neurodegeneration seen in Huntington’s disease and underscores the need for early therapeutic intervention.

SEO keywords: huntingtin protein aggregation, neuronal proteostasis, neurodegeneration mechanisms, Huntington's disease therapy.

3. N‑Glycosylation and the Glycocalyx

Key Question: Which post‑translational modification in the ER directly creates the glycocalyx on the plasma membrane?

Answer: N‑glycosylation of transmembrane proteins.

  • Process overview: In the ER lumen, oligosaccharyltransferase (OST) transfers a pre‑assembled oligosaccharide onto asparagine residues of nascent polypeptides (consensus sequence Asn‑X‑Ser/Thr).
  • From ER to plasma membrane: Glycoproteins travel through the Golgi where glycans are trimmed and extended, ultimately forming the extracellular glycocalyx.
  • Functional impact: The glycocalyx mediates cell‑cell recognition, protects against mechanical stress, and modulates signaling.

Targeted SEO phrases: N‑glycosylation pathway, ER glycosyltransferases, plasma membrane glycocalyx formation, protein glycosylation disorders.

4. Aneuploidy and Sensitivity to Proteasome Inhibitors

Key Question: A cell with aneuploidy often shows increased sensitivity to proteasome inhibitors because:

Answer: It produces excess unassembled proteins that overload the degradation system.

  • Aneuploid stress: Extra chromosomes lead to imbalanced gene dosage, causing over‑expression of many proteins that cannot be assembled into functional complexes.
  • Proteostasis burden: The UPS and ERAD pathways become saturated, making the cell vulnerable to additional proteasome blockade.
  • Therapeutic angle: Exploiting this vulnerability is an emerging strategy in cancer treatment, especially for tumors with high chromosomal instability.

SEO‑optimized terms: aneuploidy proteasome sensitivity, cancer chromosomal instability, UPS overload, targeted proteasome therapy.

5. Signal Recognition Particle (SRP) and Cotranslational Translocation

Key Question: During cotranslational translocation, what is the immediate consequence of SRP binding to the nascent peptide?

Answer: A temporary pause in translation until the ribosome‑SRP complex docks to the ER membrane.

  • SRP function: Recognizes signal sequences emerging from the ribosomal exit tunnel, halting elongation.
  • Docking step: The SRP‑ribosome complex interacts with the SRP receptor (SR) on the ER, positioning the ribosome over the Sec61 translocon.
  • Resumption of synthesis: Once docked, translation resumes, and the growing polypeptide is threaded into the ER lumen or membrane.

Relevant SEO keywords: signal recognition particle mechanism, cotranslational translocation, Sec61 channel, SRP pause translation.

6. Basophilic Appearance of Rough ER in Pancreatic Acini

Key Question: Which of the following best explains why the rough ER appears basophilic in optical microscopy of pancreatic acini?

Answer: High concentration of rRNA in ribosomes bound to the ER membrane.

  • Basophilic staining: Basic dyes (e.g., hematoxylin) bind to acidic nucleic acids, especially rRNA.
  • Rough ER composition: The ER surface is studded with ribosomes rich in rRNA, giving it a deep blue‑purple hue.
  • Clinical relevance: Recognizing basophilic rough ER helps pathologists assess secretory activity in exocrine glands.

SEO phrases: rough ER basophilic staining, pancreatic acini histology, ribosomal rRNA detection, hematoxylin‑eosin staining basics.

7. Primary Sensor in the ER‑Associated Degradation (ERAD) Pathway

Key Question: In the ERAD pathway, which protein acts as the primary sensor for misfolded proteins?

Answer: BIP (Binding Immunoglobulin Protein).

  • BIP/GRP78 role: A lumenal Hsp70 chaperone that binds exposed hydrophobic patches on nascent or misfolded proteins.
  • Quality‑control trigger: Persistent BIP binding signals that a protein has failed to fold, recruiting downstream ERAD components (e.g., E3 ubiquitin ligases).
  • Therapeutic insight: Modulating BIP activity is being explored to alleviate diseases caused by protein aggregation, such as cystic fibrosis.
  • SEO‑focused terms: BIP chaperone function, ERAD sensor proteins, unfolded protein response BIP, targeting BIP in disease.

    8. Signal Peptide Cleavage in Type 2 Membrane Proteins

    Key Question: Why does the presence of a hydrophobic internal signal sequence in type 2 membrane proteins prevent cleavage of the signal peptide?

    Answer: The internal signal serves as a permanent transmembrane anchor rather than a cleavable leader.

    • Topology: Type 2 proteins have an N‑terminal cytosolic tail followed by a single internal hydrophobic segment that halts translocation.
    • Signal peptidase limitation: Cleavage occurs only when the signal peptide emerges into the ER lumen; an internal hydrophobic segment remains embedded, shielding it from the peptidase.
    • Functional consequence: The uncleaved segment anchors the protein in the membrane, defining its orientation and function.

    SEO keywords: type 2 membrane protein topology, internal signal sequence, signal peptide cleavage inhibition, membrane protein anchoring.

    Conclusion and Further Study

    These eight topics interlink the molecular mechanisms of protein folding, ER quality control, and therapeutic exploitation of proteostasis pathways. Mastery of these concepts equips medical professionals and cell biologists to interpret disease pathology, design targeted interventions, and appreciate the delicate balance that sustains cellular health.

    For deeper exploration, consider reviewing primary literature on the unfolded protein response, recent clinical trials of proteasome inhibitors beyond multiple myeloma, and advanced imaging techniques that visualize ER dynamics in live cells.